Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

109
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
109
Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

63
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
63
Acute Coronary Syndrome III: Diagnostic studies01:30

Acute Coronary Syndrome III: Diagnostic studies

3
Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
3

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Shared splicing dysregulation in heart failure associated with dilated and ischaemic cardiomyopathy and spatial specificity across cardiac regions.

Cardiovascular research·2026
Same author

Multiomics for Risk Stratification in Atherosclerotic Cardiovascular Disease.

Circulation. Genomic and precision medicine·2026
Same author

Pros and cons of Swedish law on intellectual property rights.

European heart journal·2026
Same author

Do nurses and allied professionals need to upskill to meet developments in RNA therapeutics for CVD? A discussion paper.

European journal of cardiovascular nursing·2026
Same author

Direct RNA sequencing identified solute carrier family 2 member 1 to improve neurological outcome prediction after cardiac arrest.

Intensive care medicine experimental·2026
Same author

Bottlenecks in advancing and applying multiomic data integration-common data resources as rate-limiting drivers-the high-impact use case of atherosclerotic cardiovascular disease.

Briefings in bioinformatics·2025

Related Experiment Video

Updated: Jun 11, 2025

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

1.7K

Multiomic biomarkers after cardiac arrest.

Victoria Stopa1, Gabriele Lileikyte2, Anahita Bakochi3,4

  • 1Cardiovascular Research Unit, Department of Precision Health, Luxembourg Institute of Health, 1A-B rue Edison, 1445, Strassen, Luxembourg.

Intensive Care Medicine Experimental
|September 27, 2024
PubMed
Summary

Predicting neurological outcomes after cardiac arrest remains challenging. Multiomic signatures, analyzed with AI, show promise for improving prognostic accuracy and patient care.

Keywords:
Artificial intelligenceBiomarkersCardiac arrestClinical outcomesMachine learningMultiomicsPrognosis

More Related Videos

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K

Related Experiment Videos

Last Updated: Jun 11, 2025

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest
07:18

Author Spotlight: A Unique Mouse Model of Asphyxia-Induced Cardiac Arrest

Published on: April 14, 2023

1.7K
Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts
08:51

Author Spotlight: Integrated Multi-Omics Analysis for Unveiling Multicellular Immune Signatures in Clinical Heart Attack Cohorts

Published on: September 20, 2024

1.2K
Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

5.2K

Area of Science:

  • Biomedical research
  • Cardiology
  • Genomics and Proteomics

Background:

  • Cardiac arrest is a critical medical emergency with high mortality.
  • Accurate prediction of neurological outcomes post-cardiac arrest is crucial for patient management.
  • Current prognostic methods lack sufficient accuracy, hindering personalized treatment strategies.

Purpose of the Study:

  • To review existing omic biomarkers for predicting cardiac arrest outcomes.
  • To explore the potential of multiomic signatures in improving prognostic accuracy.
  • To identify future research directions for integrating multiomic data in cardiac arrest care.

Main Methods:

  • Comprehensive literature review of omic biomarkers.
  • Analysis of emerging technologies for multi-omics data integration.
  • Exploration of artificial intelligence and machine learning applications.

Main Results:

  • Various omic fields offer potential biomarkers for cardiac arrest prognosis.
  • Multi-omics data integration presents a promising avenue for enhanced prediction.
  • AI and machine learning can facilitate the analysis of complex multiomic datasets.

Conclusions:

  • Integrating multiomic data holds significant potential for improving cardiac arrest outcome prediction.
  • Future research should focus on developing and validating multiomic signatures.
  • Advancements in this area can lead to more personalized and effective patient care.